The findings that both NTyR and ubiquitin were significantly reduced by PPAR-δ + PPAR-γ in control and STZ cultures suggest that early responses to PPAR-δ + PPAR-γ agonist treatments in sporadic AD include reductions in nitrosative stress and ubiquitination linked to neurodegeneration. The gene discussed is PPARG; the disease is Alzheimer disease.